Zobrazeno 1 - 10
of 20
pro vyhledávání: '"M J, Pérez Castejón"'
Autor:
R, Valhondo-Rama, C G, Wakfie-Corieh, E A, Rodríguez Gallo, M J, Pérez-Castejón, J M, Brenes Sánchez, M, Herrera de la Muela, J L, Carreras-Delgado
Publikováno v:
Revista espanola de medicina nuclear e imagen molecular. 38(5)
Lymphoscintigraphy in breast cancer usually shows lymphatic drainage to the ipsilateral axilla. Drainage to extraaxillary or contralateral axillary regions is rare and there is still controversy about its management. Due to the significant clinical i
Autor:
A, Vera-Gil, M J, Pérez Castejón, J, Whyte, A, Cisneros, P, Recreo, M A, Gascón, A, Whyte, M, Lahoz, M C, Pérez Castejón
Publikováno v:
Histology and histopathology. 28(8)
We have studied the dynamic pathway of ⁶⁵Zn and its autoradiographic location in blood cells, even at the ultra-structural level. We have found evidence that tends to confirm the old biochemical postulates about the capacity of this isotope to di
Autor:
R C, Delgado Bolton, A, Ortega Candil, M J, Pérez Castejón, M, Garcerant, M N, Cabrera Martín, L, Lapeña Gutiérrez, J L, Carreras Delgado
Publikováno v:
Revista espanola de medicina nuclear. 27(2)
We present the case of a male patient with gastrointestinal stromal tumor (GIST) in whom we conducted two (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) studies, the first one prior to beginning the treatment with Glivec and th
Autor:
M N, Cabrera Martín, J A, Pasamontes Pingarrón, J L, Carreras Delgado, L, Lapeña Gutiérrez, R C, Delgado Bolton, A, Bittini Copano, M J, Pérez Castejón, C, Fernández Pérez
Publikováno v:
Revista espanola de medicina nuclear. 26(5)
18F-FDG PET has demonstrated its usefulness in detecting recurrences of differentiated thyroid cancer (DTC) with high thyroglobulin (Tg) levels and negative 131I whole-body scan (WBS); however, the number of patients analyzed is low and different stu
Autor:
S R, Martínez de Llano, R C, Delgado-Bolton, A, Jiménez-Vicioso, M J, Pérez-Castejón, J L, Carreras Delgado, E, Ramos, A, Rotger, F, Jiménez, J C, Alonso, A, Bittini, P, Domínguez, M, Almoguera, J M, Pérez-Vázquez
Publikováno v:
Revista espanola de medicina nuclear. 26(1)
Renal cell carcinoma is the most frequent solid kidney tumor. At present, PET is not the imaging test of choice, the helical CT being the best method to assess these patients. The aim of the study was to perform a meta-analysis of the literature to e
Autor:
J A, Pasamontes Pingarrón, M N, Cabrera Martín, J L, Carreras Delgado, B, Scola Yurrita, F, Calvo Manuel, M J, Pérez Castejón
Publikováno v:
Revista espanola de medicina nuclear. 25(5)
This study aims to evaluate the impact of Positron Emission Tomography on therapeutic decisions in patients with suspicion of recurrence of head and neck cancers.The diagnostic and therapeutic impact of FDG-PET was evaluated in 59 of 60 studies perfo
Autor:
G, Ruiz-Hernández, R C, Delgado-Bolton, M J, Rubio-Pérez, A, Jiménez-Vicioso, M J, Pérez-Castejón, J L, Carreras-Delgado
Publikováno v:
Revista espanola de medicina nuclear. 24(5)
To present the case report of a patient with undifferentiated and diffuse signet-ring cell gastric carcinoma in which FDG-PET evidenced recurrent disease.The patient was diagnosed of a stage III gastric carcinoma in 1994 and was treated with a subtot
Autor:
G, Ruíz-Hernández, J, Hornedo-Muguiro, P, Salinas-Hernández, M J, Pérez-Castejón, L, Lapeña-Gutiérrez, R, Montz-Andrée, J L, Carreras-Delgado
Publikováno v:
Revista espanola de medicina nuclear. 22(6)
The development of neurofibrosarcomas in patients with Von Recklinghausen disease is a rare complication that can appear in the daily clinical practice. We report a clinical case with Von Recklinghausen disease and recurrence of a left dorsal neurofi
Publikováno v:
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 46(2)
The aim of this work is to assess the diagnostic value of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG), in the early detection of tumour recurrence in already treated breast cancer patients in apparent complete remission and w
Autor:
A, Ortega, M J, Pérez-Castejón, A, Jiménez-Vicioso, R, Expósito, M, Domper, R, Montz, J L, Carreras
Publikováno v:
Revista clinica espanola. 200(8)